| Characterization of the inhibition of hepatitis C virus entry by in vitro generated and patient derived oxidized low density lipoprotein. | |
| | |
MedLine Citation:
|
PMID: 23212706 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Oxidized low density lipoprotein (oxLDL) has been reported as an inhibitor of hepatitis C virus (HCV) cell entry making it the only known component of human lipid metabolism with an anti-viral effect on HCV. However, several questions remain open including its effect on full length cell culture grown HCV (HCVcc) of different genotypes or on other steps of the viral replication cycle, its mechanism of action and whether endogenous oxLDL shares the anti-HCV properties of in vitro generated oxLDL. We combined molecular virology tools with oxLDL serum measurements in different patient cohorts to address these questions. We found that oxLDL inhibits HCVcc at least as potently as HCV pseudoparticles. There was moderate variation between genotypes with genotype 4 appearing most oxLDL sensitive. Intracellular RNA replication and assembly and release of new particles were unaffected. HCV particles entering target cells lost oxLDL sensitivity with time kinetics parallel to anti-SR-BI but significantly earlier than anti-CD81 suggesting that oxLDL acts by perturbing the interaction between HCV and SR-BI. Finally, in chronically HCV infected individuals endogenous serum oxLDL levels did not correlate with viral load, but in HCV-negative sera high endogenous oxLDL had a negative effect on HCV infectivity in vitro. In conclusion oxLDL is a potent pan-genotype HCV entry inhibitor that maintains its activity in the context of human serum and targets an early step of HCV entry. (HEPATOLOGY 2012.). |
| | |
Authors:
|
Sandra Westhaus; Dorothea Bankwitz; Stefanie Ernst; Katrin Rohrmann; Ilka Wappler; Clemens Agné; Maren Luchtefeld; Bernhard Schieffer; Christoph Sarrazin; Michael P Manns; Thomas Pietschmann; Sandra Ciesek; Thomas von Hahn |
Related Documents
:
|
23233556 - The porphyrias: advances in diagnosis and treatment. 23384676 - Complete and repeatable inactivation of hiv-1 viral particles in suspension using a pho... 23339916 - Interferon γ in patients with hiv/aids and suspicion or latent tuberculosis infection. 22955926 - Profound metabolic, functional and cytolytic differences characterize hiv-specific cd8 ... 7728886 - Rheumatoid arthritis and connective tissue disorders: sub-saharan africa. 7615736 - Potential sources of sporadic human infection with yersinia enterocolitica serovar o:8 ... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-12-5 |
Journal Detail:
|
Title: Hepatology (Baltimore, Md.) Volume: - ISSN: 1527-3350 ISO Abbreviation: Hepatology Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-12-5 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8302946 Medline TA: Hepatology Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 American Association for the Study of Liver Diseases. |
Affiliation:
|
Institute for Molecular Biology, Medizinische Hochschule Hannover, Hannover, Germany; Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Different patterns of oviposition learning in two closely related ectoparasitoid wasps with contrast...
Next Document: Trehalose preserves the integrity of lyophilized phycoerythrin-antihuman CD8 antibody conjugates and...